Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fedele, D.
Right arrow Articles by Parazzini, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fedele, D.
Right arrow Articles by Parazzini, F.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 21, Issue 11 1973-1977, Copyright © 1998 by American Diabetes Association


ARTICLES

Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici

D Fedele, C Coscelli, F Santeusanio, A Bortolotti, L Chatenoud, E Colli, M Landoni and F Parazzini
Cattedra Malattie Metaboliche, Universita di Padova, Italy.

OBJECTIVE: Our objective was to analyze the prevalence and risk factors for erectile dysfunction (ED) in men with diabetes in Italy in a cross-sectional study. RESEARCH DESIGN AND METHODS: Eligible for the study were men aged 20-69 years with a diagnosis of IDDM or NIDDM who were observed on randomly selected days in 178 diabetes centers in Italy. ED was defined as a failure to achieve and maintain an erection sufficient for satisfactory sexual performance. RESULTS: Of the 9,868 diabetic men interviewed, 3,534 (35.8%) reported ED. The prevalence increased with age, from 4.6% in men aged 20-29 to 45.5% in those aged > or =60 years (test for trend, P = 0.0001). After taking into account the confounding role of age, men with NIDDM reported ED less frequently than did men with IDDM (odds ratio [OR], 0.7; 95% CI 0.6-0.8). In comparison with men reporting diabetes lasting < or =5 years, the ORs for ED were 1.3 and 2.0 for subjects with diabetes lasting 6-10 and 11-30 years, respectively. In comparison with men with good metabolic control, the ORs for ED were 1.7 and 2.3 in men with fair and poor control, respectively. A history of diabetes-related arterial, retinal, or renal diseases and neuropathy was associated with an increased risk of ED. Finally, in comparison with never-smokers, the ORs for ED were 1.5 (95% CI 1.3-1.6) for current smokers and 1.4 (95% CI 1.3-1.6) for ex-smokers. The OR increased with number of cigarettes smoked per day: in comparison with men smoking <12 cigarettes per day, the OR was 1.5 (95% CI 1.3-1.7) for those smoking > or =30 cigarettes day. CONCLUSIONS: The study offers a quantitative estimate of the prevalence of ED and of its main risk factors in Italian men with diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
D. Kapoor, H. Aldred, S. Clark, K. S. Channer, and T. H. Jones
Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes: Correlations with bioavailable testosterone and visceral adiposity
Diabetes Care, April 1, 2007; 30(4): 911 - 917.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J. Falkensammer, A. G. Hakaim, C. E. Falkensammer, G. A. Broderick, J. E. Crook, M. G. Heckman, W. A. Oldenburg, and B. Hugl
Prevalence of erectile dysfunction in vascular surgery patients
Vascular Medicine, February 1, 2007; 12(1): 17 - 22.
[Abstract] [PDF]


Home page
Eur Heart JHome page
P. Montorsi, P. M. Ravagnani, S. Galli, F. Rotatori, F. Veglia, A. Briganti, A. Salonia, F. Deho, P. Rigatti, F. Montorsi, et al.
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial
Eur. Heart J., November 2, 2006; 27(22): 2632 - 2639.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Salonia, R. Lanzi, M. Scavini, M. Pontillo, E. Gatti, G. Petrella, G. Licata, R. E. Nappi, E. Bosi, A. Briganti, et al.
Sexual Function and Endocrine Profile in Fertile Women With Type 1 Diabetes
Diabetes Care, February 1, 2006; 29(2): 312 - 316.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. G. Stoyanovitch, M. A. Johnson, D. K. Clifton, R. A. Steiner, and G. S. Fraley
Galanin-Like Peptide Rescues Reproductive Function in the Diabetic Rat
Diabetes, August 1, 2005; 54(8): 2471 - 2476.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
O. Kalter-Leibovici, J. Wainstein, A. Ziv, I. Harman-Bohem, H. Murad, I. Raz, and for the Israel Diabetes Research Group (IDRG) Inve
Clinical, Socioeconomic, and Lifestyle Parameters Associated With Erectile Dysfunction Among Diabetic Men
Diabetes Care, July 1, 2005; 28(7): 1739 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. S. Brown, H. Wessells, M. B. Chancellor, S. S. Howards, W. E. Stamm, A. E. Stapleton, W. D. Steers, S. K. Van Den Eeden, and K. T. McVary
Urologic Complications of Diabetes
Diabetes Care, January 1, 2005; 28(1): 177 - 185.
[Full Text] [PDF]


Home page
Diabetes CareHome page
I. Goldstein, J. M. Young, J. Fischer, K. Bangerter, T. Segerson, and T. Taylor
Vardenafil, a New Phosphodiesterase Type 5 Inhibitor, in the Treatment of Erectile Dysfunction in Men With Diabetes: A multicenter double-blind placebo-controlled fixed-dose study
Diabetes Care, March 1, 2003; 26(3): 777 - 783.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Kantor, W. B. Bilker, D. B. Glasser, and D. J. Margolis
Prevalence of Erectile Dysfunction and Active Depression: An Analytic Cross-Sectional Study of General Medical Patients
Am. J. Epidemiol., December 1, 2002; 156(11): 1035 - 1042.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. G. Bacon, F. B. Hu, E. Giovannucci, D. B. Glasser, M. A. Mittleman, and E. B. Rimm
Association of Type and Duration of Diabetes With Erectile Dysfunction in a Large Cohort of Men
Diabetes Care, August 1, 2002; 25(8): 1458 - 1463.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
R. W. Jones and J C. Gingell
Review: The vascular system and erectile dysfunction in diabetes -- the role of penile Doppler
The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 263 - 265.
[Abstract] [PDF]


Home page
Diabetes CareHome page
G. De Berardis, M. Franciosi, M. Belfiglio, B. Di Nardo, S. Greenfield, S. H. Kaplan, F. Pellegrini, M. Sacco, G. Tognoni, M. Valentini, et al.
Erectile Dysfunction and Quality of Life in Type 2 Diabetic Patients: A serious problem too often overlooked
Diabetes Care, February 1, 2002; 25(2): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
F. R. Kandeel, V. K. T. Koussa, and R. S. Swerdloff
Male Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and Treatment
Endocr. Rev., June 1, 2001; 22(3): 342 - 388.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
D. Fedele, A. Bortolotti, C. Coscelli, F. Santeusanio, L. Chatenoud, E. Colli, M. Lavezzari, M. Landoni, F. Parazzini, and Gruppo Italiano Studio Deficit Erettile nei Diabet
Erectile dysfunction in Type 1 and Type 2 diabetics in Italy
Int. J. Epidemiol., June 1, 2000; 29(3): 524 - 531.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.